U.S. markets open in 6 hours 35 minutes
  • S&P Futures

    4,274.50
    +3.25 (+0.08%)
     
  • Dow Futures

    34,350.00
    +17.00 (+0.05%)
     
  • Nasdaq Futures

    14,358.50
    +19.50 (+0.14%)
     
  • Russell 2000 Futures

    2,333.10
    +1.10 (+0.05%)
     
  • Crude Oil

    74.21
    +0.16 (+0.22%)
     
  • Gold

    1,782.60
    +4.80 (+0.27%)
     
  • Silver

    26.19
    +0.11 (+0.41%)
     
  • EUR/USD

    1.1935
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.5360
    0.0000 (0.00%)
     
  • Vix

    15.62
    -0.35 (-2.19%)
     
  • GBP/USD

    1.3913
    +0.0038 (+0.27%)
     
  • USD/JPY

    110.6750
    -0.0850 (-0.08%)
     
  • BTC-USD

    34,525.47
    +1,440.39 (+4.35%)
     
  • CMC Crypto 200

    826.33
    -16.31 (-1.94%)
     
  • FTSE 100

    7,136.07
    +26.10 (+0.37%)
     
  • Nikkei 225

    29,048.02
    -18.16 (-0.06%)
     

Targovax to present at the 4th Annual Next Gen Immuno-oncology Virtual Congress-US Edition

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

OSLO, Norway, June 28, 2021 /PRNewswire/ -- Targovax ASA, today announces that Victor Levitsky, Chief Scientific Officer of Targovax, is invited to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition.

4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition, virtual

Date: 29 June 2021
Presenter: Victor Levitsky (CSO)
Time: 14:15 EDT / 20:15 CET
Title: Clinical efficacy and immuno-modulatory properties of oncolytic adenovirus ONCOS-102

CONTACT:
For further information, please contact:
Oystein Soug, CEO
Phone: +47 906 56 525
Email: oystein.soug@targovax.com

Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: renate.birkeli@targovax.com

Media enquires:
Andreas Tinglum - Corporate Communications (Norway)
Phone: +47 9300 1773
Email: andreas.tinglum@corpcom.no

IR enquires:
Kim Sutton Golodetz - LHA Investor Relations (US)
Email: kgolodetz@lhai.com
Phone: +1 212-838-3777

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/targovax/r/targovax-to-present-at-the-4th-annual-next-gen-immuno-oncology-virtual-congress-us-edition,c3375255

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/targovax-to-present-at-the-4th-annual-next-gen-immuno-oncology-virtual-congress-us-edition-301320771.html

SOURCE Targovax